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Abstract
© 2016,  International  Society  for  Cellular  Oncology.Background:  Cancer  development  is  a
complex process involving both genetic and epigenetic changes. Genetic changes in oncogenes
and tumor-suppressor genes are generally considered as primary causes, since these genes
may directly regulate cellular growth. In addition, it has been found that changes in epigenetic
factors, through mutation or altered gene expression, may contribute to cancer development. In
the nucleus of eukaryotic cells DNA and histone proteins form a structure called chromatin
which consists of nucleosomes that, like beads on a string, are aligned along the DNA strand.
Modifications in chromatin structure are essential for cell type-specific activation or repression
of gene transcription, as well  as other processes such as DNA repair,  DNA replication and
chromosome segregation. Alterations in epigenetic factors involved in chromatin dynamics may
accelerate cell cycle progression and, ultimately, result in malignant transformation. Abnormal
expression of remodeler and modifier enzymes, as well  as histone variants, may confer to
cancer  cells  the ability  to  reprogram their  genomes and to  yield,  maintain  or  exacerbate
malignant hallmarks. At the end, genetic and epigenetic alterations that are encountered in
cancer cells may culminate in chromatin changes that may, by altering the quantity and quality
of gene expression, promote cancer development. Methods: During the last decade a vast
number  of  studies  has  uncovered  epigenetic  abnormalities  that  are  associated  with  the
(anomalous) packaging and remodeling of chromatin in cancer genomes. In this review I will
focus on recently published work dealing with alterations in the primary structure of chromatin
resulting  from  imprecise  arrangements  of  nucleosomes  along  DNA,  and  its  functional
implications for cancer development. Conclusions: The primary chromatin structure is regulated
by a variety of epigenetic mechanisms that may be deregulated through gene mutations and/or
gene expression alterations. In recent years, it has become evident that changes in chromatin
structure  may  coincide  with  the  occurrence  of  cancer  hallmarks.  The  functional
interrelationships  between  such  epigenetic  alterations  and  cancer  development  are  just
becoming manifest and, therefore, the oncology community should continue to explore the
molecular mechanisms governing the primary chromatin structure, both in normal and in cancer
cells, in order to improve future approaches for cancer detection, prevention and therapy, as
also for circumventing drug resistance.
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